A detailed history of Ria Advisory Group LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Ria Advisory Group LLC holds 43,666 shares of NVNO stock, worth $141,041. This represents 0.1% of its overall portfolio holdings.

Number of Shares
43,666
Holding current value
$141,041
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$3.94 - $6.65 $172,044 - $290,378
43,666 New
43,666 $238 Million

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $30.6M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Ria Advisory Group LLC Portfolio

Follow Ria Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ria Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ria Advisory Group LLC with notifications on news.